Pulike Biological Engineering, Inc. (603566.SS)
CNY 13.54
(-1.24%)
CNY 13.54
(-1.24%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 174.51 Million CNY | 3.99% |
| 2022 | 167.82 Million CNY | -31.26% |
| 2021 | 244.13 Million CNY | 7.2% |
| 2020 | 227.74 Million CNY | 108.47% |
| 2019 | 109.24 Million CNY | -19.44% |
| 2018 | 135.61 Million CNY | 18.77% |
| 2017 | 114.18 Million CNY | -39.26% |
| 2016 | 188 Million CNY | 32.64% |
| 2015 | 141.74 Million CNY | 1.06% |
| 2014 | 140.25 Million CNY | -13.88% |
| 2013 | 162.86 Million CNY | 26.04% |
| 2012 | 129.21 Million CNY | 11.99% |
| 2011 | 115.37 Million CNY | 37.37% |
| 2010 | 83.99 Million CNY | -9.45% |
| 2009 | 92.75 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 32.32 Million CNY | -30.69% |
| 2024 Q1 | 27.3 Million CNY | 694.42% |
| 2024 Q2 | 46.63 Million CNY | 70.8% |
| 2023 Q2 | 52.03 Million CNY | -18.74% |
| 2023 Q4 | -4.59 Million CNY | -107.46% |
| 2023 FY | 174.51 Million CNY | 3.99% |
| 2023 Q3 | 61.61 Million CNY | 18.4% |
| 2023 Q1 | 64.03 Million CNY | 55.2% |
| 2022 Q3 | 52.59 Million CNY | 23.06% |
| 2022 FY | 167.82 Million CNY | -31.26% |
| 2022 Q4 | 41.26 Million CNY | -21.55% |
| 2022 Q1 | 37.52 Million CNY | 177.79% |
| 2022 Q2 | 42.73 Million CNY | 13.89% |
| 2021 Q4 | 13.5 Million CNY | -79.85% |
| 2021 FY | 244.13 Million CNY | 7.2% |
| 2021 Q1 | 86.84 Million CNY | 29.1% |
| 2021 Q3 | 67.02 Million CNY | -12.67% |
| 2021 Q2 | 76.75 Million CNY | -11.63% |
| 2020 Q2 | 60.62 Million CNY | 2.06% |
| 2020 Q1 | 59.4 Million CNY | 319.01% |
| 2020 FY | 227.74 Million CNY | 108.47% |
| 2020 Q3 | 40.44 Million CNY | -33.29% |
| 2020 Q4 | 67.27 Million CNY | 66.33% |
| 2019 Q1 | 14.41 Million CNY | -12.75% |
| 2019 FY | 109.24 Million CNY | -19.44% |
| 2019 Q3 | 29.99 Million CNY | -40.79% |
| 2019 Q4 | 14.17 Million CNY | -52.73% |
| 2019 Q2 | 50.65 Million CNY | 251.35% |
| 2018 Q1 | 38.55 Million CNY | 77.14% |
| 2018 FY | 135.61 Million CNY | 18.77% |
| 2018 Q3 | 42.65 Million CNY | 12.6% |
| 2018 Q2 | 37.88 Million CNY | -1.73% |
| 2018 Q4 | 16.52 Million CNY | -61.26% |
| 2017 Q4 | 21.76 Million CNY | -28.61% |
| 2017 FY | 114.18 Million CNY | -39.26% |
| 2017 Q3 | 30.48 Million CNY | 6.71% |
| 2017 Q2 | 28.56 Million CNY | -14.4% |
| 2017 Q1 | 33.37 Million CNY | 4.96% |
| 2016 Q2 | 46.44 Million CNY | 6.15% |
| 2016 FY | 188 Million CNY | 32.64% |
| 2016 Q4 | 31.79 Million CNY | -51.84% |
| 2016 Q3 | 66.01 Million CNY | 42.15% |
| 2016 Q1 | 43.75 Million CNY | 78.11% |
| 2015 FY | 141.74 Million CNY | 1.06% |
| 2015 Q4 | 24.56 Million CNY | -47.22% |
| 2015 Q3 | 46.54 Million CNY | 94.71% |
| 2015 Q2 | 23.9 Million CNY | -48.85% |
| 2015 Q1 | 46.73 Million CNY | 33.47% |
| 2014 Q1 | 37.47 Million CNY | 0.0% |
| 2014 Q4 | 35.01 Million CNY | -33.02% |
| 2014 Q3 | 52.26 Million CNY | 237.21% |
| 2014 Q2 | 15.5 Million CNY | -58.63% |
| 2014 FY | 140.25 Million CNY | -13.88% |
| 2013 FY | 162.86 Million CNY | 26.04% |
| 2012 FY | 129.21 Million CNY | 11.99% |
| 2011 FY | 115.37 Million CNY | 37.37% |
| 2010 FY | 83.99 Million CNY | -9.45% |
| 2009 FY | 92.75 Million CNY | 0.0% |